Corpus ID: 101472733

EXOSOMAL CURCUMIN: ITS BIOAVAILABILITY AND POTENTIAL ANTI- INFLAMMATION ACTIVITY

@inproceedings{Sun2010EXOSOMALCI,
  title={EXOSOMAL CURCUMIN: ITS BIOAVAILABILITY AND POTENTIAL ANTI- INFLAMMATION ACTIVITY},
  author={D. Sun},
  year={2010}
}
Curcumin, a pleiotropic polyphenol derived from turmeric plants Curcuma Longa with rhizome, exhibits strong evidence as an anti-inflammation, anti-oxidant and anti-cancer reagent both in vitro and in vivo. Due to its low stability and systemic bioavailability, a large amount of curcumin has to be administrated to achieve therapeutic effects both in animal and in human. The major effort to overcome this barrier is making by encapsulation of curcumin into nanoparticles such as polymers and… Expand

Figures and Tables from this paper

References

SHOWING 1-10 OF 164 REFERENCES
An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells.
  • 117
Bioavailability of curcumin: problems and promises.
  • 3,317
  • PDF
Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
  • 352
Inhibition of LPS-induced production of inflammatory factors in the macrophages by mono-carbonyl analogues of curcumin
  • G. Liang, H. Zhou, +6 authors X. Li
  • Chemistry, Medicine
  • Journal of cellular and molecular medicine
  • 2009
  • 58
Inhibition of tumor necrosis factor by curcumin, a phytochemical.
  • M. Chan
  • Medicine
  • Biochemical pharmacology
  • 1995
  • 298
Exosome Function: From Tumor Immunology to Pathogen Biology
  • 619
Exosomes – nanovesicles with possible roles in allergic inflammation
  • 88
Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells.
  • 396
MD‐2 as the target of curcumin in the inhibition of response to LPS
  • 112
...
1
2
3
4
5
...